# Alexandria Venture Investments: portfolio, investments and team

> Alexandria Venture Investments is a vc firm. 126 investments on record, 13 in the last 12 months, latest Aug 2026. Portfolio, stages, co-investors and team.

Source: https://millionrounds.com/fund/alexandria-venture-investments (Millionrounds; every figure on the page links to its filing or article)

[Investor](https://millionrounds.com/investors)

# Alexandria Venture Investments

Last cheque observed Aug 2026; 126 cheques on record.

Deploying now VC firm

Series A Venture Series B Biotechnology Health Care

Deploying now

**45%** of best year **13** **cheques in 12 months**, 126 on record

Since the last cheque **74** days **00** hrs **00** min **00** sec

Median round **$40M** Rounds led **0 of 126** Sole investor **13 rounds** Mostly in **United States, 92%**

Pitch Alexandria Venture Investments

## Alexandria Venture Investments highlights

- 01 13 cheques in the last 12 months
- 02 Mostly Series A and Venture: 63% of its rounds
- 03 Sole investor in 13 rounds, median $12M

## What they do

- **Type:** VC firm (from a list, unverified)
- **Cheque size:** Not stated
- **Sectors:** Biotechnology Health Care
- **Cold pitches:** Not stated

## The record

Every round we can evidence, newest first **126 appearances**

- **2026** 10 rounds
- **Aug** **[Khartis Therapeutics](https://millionrounds.com/company/khartis-therapeutics)** Series B · US · Ventureburn **$50M** With 5 others
- **Aug** **[Georgiamune](https://millionrounds.com/company/georgiamune)** Series B · US **$93M** With 3 others
- **Jun** **[Vedana Therapeutics](https://millionrounds.com/company/vedana-therapeutics)** Series A · US **$46M** With 1 other
- **May** **[CREATE Medicines](https://millionrounds.com/company/create-medicines)** Series B · US · Hatteras Venture Partners **$122M** With 4 others
- **May** **[Autoimmunity BioSolutions](https://millionrounds.com/company/autoimmunity-biosolutions)** Seed · US **$1.0M** Sole investor
- **Apr** **[Fathom Therapeutics](https://millionrounds.com/company/fathom-therapeutics)** Series A · US · AlleyWatch **$47M** With 8 others
- **Apr** **[Neomorph](https://millionrounds.com/company/neomorph)** Series B · US · TechStartups **$100M** With 4 others
- **Apr** **[Kytopen](https://millionrounds.com/company/kytopen)** Venture · US **Undisclosed** With 2 others
- **Jan** **[Recludix Pharma](https://millionrounds.com/company/recludix-pharma)** Venture · US **Undisclosed** With 2 others
- **Jan** **[TwoStep Therapeutics](https://millionrounds.com/company/twostep-therapeutics)** Series A · US **$21M** With 2 others
- **2025** 23 rounds
- **Nov** **[Accipiter Biosciences](https://millionrounds.com/company/accipiter-biosciences)** Seed · US · Columbus Venture Partners **$13M** With 8 others
- **Nov** **[CrossBridge Bio](https://millionrounds.com/company/crossbridge-bio)** Grant · US **$15M** With 1 other
- **Nov** **[Eclipse Bioinnovations](https://millionrounds.com/company/eclipse-bioinnovations)** Venture · US **$4.9M** Sole investor
- **Oct** **[AeroRx Therapeutics](https://millionrounds.com/company/aerorx-therapeutics)** Series A · US **$21M** With 1 other
- **Oct** **[Tr1x](https://millionrounds.com/company/tr1x)** Venture · US **$50M** Sole investor
- **Oct** **[NILO Therapeutics](https://millionrounds.com/company/nilo-therapeutics)** Series A · US **$101M** With 2 others
- **Sept** **[HAYA Therapeutics](https://millionrounds.com/company/haya-therapeutics)** Venture · CH **Undisclosed** With 4 others
- **Sept** **[Crystalys Therapeutics](https://millionrounds.com/company/crystalys-therapeutics)** Series A · US **$205M** With 3 others
- **Sept** **[Dualitas Therapeutics](https://millionrounds.com/company/dualitas-therapeutics)** Series A · US **$65M** With 4 others
- **Sept** **[Thryv Therapeutics](https://millionrounds.com/company/thryv-therapeutics)** Venture · CA **Undisclosed** With 1 other
- **Aug** **[Leal Therapeutics](https://millionrounds.com/company/leal-therapeutics)** Series A · US **$30M** With 2 others
- **Jul** **[Dispatch Bio](https://millionrounds.com/company/dispatch-bio)** Series A · US **$216M** With 1 other
- **Jul** **[Harpe Bio](https://millionrounds.com/company/harpe-bio)** Debt · US **$975K** With 1 other
- **Jun** **[Arialys Therapeutics](https://millionrounds.com/company/arialys-therapeutics)** Venture · US **$15M** Sole investor
- **Jun** **[GeneCentric Therapeutics](https://millionrounds.com/company/genecentric-therapeutics)** Series C · US **$8.0M** With 2 others
- **May** **[Remedy Plan Therapeutics](https://millionrounds.com/company/remedy-plan-therapeutics)** Venture · US **$18M** Sole investor
- **Apr** **[March Biosciences](https://millionrounds.com/company/march-biosciences)** Grant · US **$200K** With 2 others
- **Apr** **[Hoofprint Biome](https://millionrounds.com/company/hoofprint-biome)** Series A · US **$15M** With 4 others
- **Apr** **[AIRNA](https://millionrounds.com/company/airna)** Series B · US · LifeLink Ventures **$155M** With 4 others
- **Apr** **[Solu Therapeutics](https://millionrounds.com/company/solu-therapeutics)** Series A · US **$41M** With 3 others
- **Mar** **[Stratus Therapeutics](https://millionrounds.com/company/stratus-therapeutics)** Series A **$50M** With 2 others
- **Mar** **[Garuda Therapeutics](https://millionrounds.com/company/garuda-therapeutics)** Series A · US **$50M** With 2 others
- **Jan** **[Inari](https://millionrounds.com/company/inari)** Growth · US **$144M** With 2 others
- **2024** 28 rounds
- **Dec** **[Pleno](https://millionrounds.com/company/pleno)** Series B · US **$25M** With 2 others
- **Dec** **[Ten63 Therapeutics](https://millionrounds.com/company/ten63-therapeutics)** Venture · US **Undisclosed** With 3 others
- **Dec** **[Meiogenix](https://millionrounds.com/company/meiogenix)** Venture · FR **Undisclosed** With 4 others
- **Nov** **[CrossBridge Bio](https://millionrounds.com/company/crossbridge-bio)** Seed · US **$10M** Sole investor
- **Nov** **[OverT Bio](https://millionrounds.com/company/overt-bio)** Grant · US **$120K** With 4 others
- **Nov** **[Autoimmunity BioSolutions](https://millionrounds.com/company/autoimmunity-biosolutions)** Seed · US **$2.0M** Sole investor
- **Nov** **[Valora Therapeutics](https://millionrounds.com/company/valora-therapeutics)** Seed · US **$30M** With 1 other

An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.

## The team

We hold **2** people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.

## The cheque

Series A Venture Series B

Median round joined **$40M** the round, not its cheque Alone, median **$12M**

Led 0 of 126 rounds **0%**

- **Sole investor:** 13 rounds
- **Last cheque:** Aug 2026

Rounds by stage said on their site

- Series A *43*
- Venture *31*
- Series B *18*
- Seed *13*
- Grant *10*
- Series C *3*

Cheques by month Led Joined

Nov 2023 Oct 2026

Often in the room with

- [ARCH Venture Partners](https://millionrounds.com/fund/arch-venture-partners) 14
- [Eli Lilly](https://millionrounds.com/fund/eli-lilly) 12
- [Casdin Capital](https://millionrounds.com/fund/casdin-capital) 10
- [AbbVie](https://millionrounds.com/fund/abbvie) 6
- [Catalio Capital Management](https://millionrounds.com/fund/catalio-capital-management) 6
- [Flagship Pioneering](https://millionrounds.com/fund/flagship-pioneering) 6

**Pitching Alexandria Venture Investments?** Put them on your fundraising board with this record on the card, and follow them to hear when they write a new cheque.

Add to your CRM *→*

## Who they invest alongside

The investors most often in the same rounds as Alexandria Venture Investments. A count of rooms they were both in, not a relationship either has claimed.

[**ARCH Venture Partners** VC firm **14** rounds together](https://millionrounds.com/fund/arch-venture-partners)[**Eli Lilly** Corporate VC **12** rounds together](https://millionrounds.com/fund/eli-lilly)[**Casdin Capital** VC firm **10** rounds together](https://millionrounds.com/fund/casdin-capital)[**AbbVie** Corporate VC **6** rounds together](https://millionrounds.com/fund/abbvie)[**Catalio Capital Management** VC firm **6** rounds together](https://millionrounds.com/fund/catalio-capital-management)[**Flagship Pioneering** VC firm **6** rounds together](https://millionrounds.com/fund/flagship-pioneering)[**National Science Foundation** Government **6** rounds together](https://millionrounds.com/fund/nsf-small-business-innovation-research-small-business-techno)[**S32** VC firm **6** rounds together](https://millionrounds.com/fund/s32)[**5AM Ventures** VC firm **5** rounds together](https://millionrounds.com/fund/5am-ventures)[**Cormorant Asset Management** Private equity **5** rounds together](https://millionrounds.com/fund/cormorant-asset-management)[**DCVC** VC firm **5** rounds together](https://millionrounds.com/fund/data-collective)[**Deerfield** VC firm **5** rounds together](https://millionrounds.com/fund/deerfield)

## Recently backed

The latest companies Alexandria Venture Investments put money into.

[**Vedana Therapeutics** $46M · Jun 2026](https://millionrounds.com/company/vedana-therapeutics)[**CREATE Medicines** $122M · May 2026](https://millionrounds.com/company/create-medicines)[**Autoimmunity BioSolutions** $1.0M · May 2026](https://millionrounds.com/company/autoimmunity-biosolutions)[**Kytopen** Apr 2026](https://millionrounds.com/company/kytopen)[**Recludix Pharma** Jan 2026](https://millionrounds.com/company/recludix-pharma)[**TwoStep Therapeutics** $21M · Jan 2026](https://millionrounds.com/company/twostep-therapeutics)

## Quick answers about Alexandria Venture Investments

### What does Alexandria Venture Investments invest in?

Alexandria Venture Investments invests most often at Series A and Venture (63% of the rounds on record), in sectors such as Biotechnology and Health Care.

### How active is Alexandria Venture Investments?

126 investments on record, 13 of them in the last 12 months. The most recent was in Aug 2026.

### What has Alexandria Venture Investments invested in recently?

Its most recent investments on record: Khartis Therapeutics (Series B, Aug 2026), Georgiamune (Series B, Aug 2026) and Vedana Therapeutics (Series A, Jun 2026).

### How big are Alexandria Venture Investments's cheques?

The median round it joins is $40M.

### Does Alexandria Venture Investments lead rounds?

Rarely, if at all: none of its 126 investments on record names it as the lead.

### Where does Alexandria Venture Investments invest?

Most of the companies it backs are in the United States (92%).

### Is Alexandria Venture Investments investing now?

Yes: it is actively investing, with 13 investments in the last 12 months.

### Who does Alexandria Venture Investments invest alongside?

Most often ARCH Venture Partners (14 rounds together), Eli Lilly (12 rounds together) and Casdin Capital (10 rounds together).

## Raising now?

Find the investors who back rounds like yours, and keep every conversation on one fundraising board.

Find similar investorsOpen your CRM

Built from the rounds we watched, its filings and its own website, refreshed every night. [How we count](https://millionrounds.com/methodology) · [Report a correction](https://millionrounds.com/corrections?slug=alexandria-venture-investments) · [Is this your firm? Claim it](https://millionrounds.com/claim?org=alexandria-venture-investments)